BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27727006)

  • 1. QTc interval lengthening in first-episode schizophrenia (FES) patients in the earliest stages of antipsychotic treatment.
    Zhai D; Lang Y; Dong G; Liu Y; Wang X; Zhou D; Cui T; Yang Y; Zhang W; Zhao Y; Zhang R
    Schizophr Res; 2017 Jan; 179():70-74. PubMed ID: 27727006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QTc interval in a sample of long-term schizophrenia inpatients.
    Ramos-Ríos R; Arrojo-Romero M; Paz-Silva E; Carballal-Calvo F; Bouzón-Barreiro JL; Seoane-Prado J; Codesido-Barcala R; Crespí-Armenteros A; Fernández-Pérez R; López-Moríñigo JD; Tortajada-Bonaselt I; Diaz FJ; de Leon J
    Schizophr Res; 2010 Jan; 116(1):35-43. PubMed ID: 19892525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors.
    Spellmann I; Reinhard MA; Veverka D; Zill P; Obermeier M; Dehning S; Schennach R; Müller N; Möller HJ; Riedel M; Musil R
    Eur Arch Psychiatry Clin Neurosci; 2018 Jun; 268(4):383-390. PubMed ID: 29429138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia.
    Ozeki Y; Fujii K; Kurimoto N; Yamada N; Okawa M; Aoki T; Takahashi J; Ishida N; Horie M; Kunugi H
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):401-5. PubMed ID: 20079791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics.
    Yang FD; Wang XQ; Liu XP; Zhao KX; Fu WH; Hao XR; Zhang XL; Huang GS; Qu SC; Bai JS; Huang XF; Kosten TR; Zhang XY
    Psychopharmacology (Berl); 2011 Jul; 216(1):9-16. PubMed ID: 21301815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiometabolic risk in first-episode schizophrenia (FES) patients with the earliest stages of both illness and antipsychotic treatment.
    Zhai D; Cui T; Xu Y; Feng Y; Wang X; Yang Y; Li S; Zhou D; Dong G; Zhao Y; Yang Y; Zhang R
    Schizophr Res; 2017 Jan; 179():41-49. PubMed ID: 27613506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for QTc prolongation in schizophrenic patients taking antipsychotics.
    Lin CH; Chen MC; Wang SY; Lin CY
    J Formos Med Assoc; 2004 Jun; 103(6):437-41. PubMed ID: 15278188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QTc variability in schizophrenia patients treated with antipsychotics and healthy controls.
    Rettenbacher MA; Eder-Ischia U; Bader A; Edlinger M; Hofer A; Hummer M; Kemmler G; Weiss EM; Hochleitner M; Fleischhacker WW
    J Clin Psychopharmacol; 2005 Jun; 25(3):206-10. PubMed ID: 15876897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QTc interval in patients with schizophrenia receiving antipsychotic treatment as monotherapy or polypharmacy.
    Elliott A; Mørk TJ; Højlund M; Christensen T; Jeppesen R; Madsen N; Viuff AG; Hjorth P; Nielsen JC; Munk-Jørgensen P
    CNS Spectr; 2018 Aug; 23(4):278-283. PubMed ID: 28659221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of antipsychotics and QTc prolongation: a pilot study.
    Høimark L; Uhrskov Sørensen L; Vukelic Andersen L
    Nord J Psychiatry; 2020; 74(5):374-379. PubMed ID: 32105154
    [No Abstract]   [Full Text] [Related]  

  • 12. QTc prolongation in schizophrenia patients in Asia: clinical correlates and trends between 2004 and 2008/2009.
    Xiang YT; Chiu HF; Ungvari GS; Correll CU; Lai KY; Wang CY; Si TM; Lee EH; He YL; Yang SY; Chong MY; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Tan CH; Shinfuku N
    Hum Psychopharmacol; 2015 Mar; 30(2):94-9. PubMed ID: 25611192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in the effect of four second-generation antipsychotics on QTc interval in patients with schizophrenia.
    Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
    Hum Psychopharmacol; 2013 May; 28(3):215-9. PubMed ID: 23553637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Real-World Study of Risk Factors for QTc Prolongation in Schizophrenia Patients Receiving Atypical Antipsychotics.
    He L; Yu Y; Zhang L; He S; Yu W; Li L; Huang J; Li H
    J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):71-74. PubMed ID: 34928562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study.
    Correll CU; Harris J; Figen V; Kane JM; Manu P
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):365-8. PubMed ID: 21823910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged QTc intervals in medicated patients with schizophrenia.
    Chong SA; Mythily ; Lum A; Goh HY; Chan YH
    Hum Psychopharmacol; 2003 Dec; 18(8):647-9. PubMed ID: 14696025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of QTc interval and antipsychotics.
    Agelink MW
    Am J Psychiatry; 2002 Jun; 159(6):1063; author reply 1064. PubMed ID: 12042206
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term treatment with antipsychotic drugs in conventional doses prolonged QTc dispersion, but did not increase ventricular tachyarrhythmias in patients with schizophrenia in the absence of cardiac disease.
    Kitayama H; Kiuchi K; Nejima J; Katoh T; Takano T; Hayakawa H
    Eur J Clin Pharmacol; 1999 Jun; 55(4):259-62. PubMed ID: 10424317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia, antipsychotic drugs, and cardiovascular disease.
    Glassman AH
    J Clin Psychiatry; 2005; 66 Suppl 6():5-10. PubMed ID: 16107178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.